CSIMarket
 
Elutia Inc   (NASDAQ: ELUT)
Other Ticker:  
 
 

Elutia Inc Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics


 
Due to inventory build up in the first quarter 2025, Elutia Inc 's inventory turnover ratio sequentially decreased to 3.48 in the first quarter 2025, otherwise the ratio remained above the average, as ELUT's markets remain strong.Elutia Inc 's average inventory processing period in the Mar 31 2025 quarter, has increased to 105 days, from 96 days, in the Dec 31 2024 quarter.

Within Healthcare sector 108 other companies have achieved higher inventory turnover ratio. While Inventory turnover ratio total ranking has improved so far during the I Quarter 2025, to 799, from total ranking in the fourth quarter 2024 at 928.

ELUT Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Elutia Inc Market Share?

What is Inventory Turnover Ratio?


ELUT Inventory Turnover Ratio (Mar 31 2025)
I. Quarter
(Dec 31 2024)
IV. Quarter
(Sep 30 2024)
III. Quarter
(Jun 30 2024)
II. Quarter
(Mar 31 2024)
III. Quarter
Y / Y Inventory Growth 40.43 % 1.51 % -44.13 % -66.41 % -72.39 %
Y / Y Cost of Sales Growth 0 % -28.94 % 0 % -66.67 % -55.35 %
Inventory Turnover Ratio (TTM) 3.48 3.79 4.29 3.54 3.64
ELUT's Total Ranking # 799 # 928 # 721 # 817 # 721
Average inventory processing period 105 96 85 103 100
Seq. Inventory Growth 9.59 % 7.65 % 16.63 % 2.06 % -20.79 %
Seq. Cost of Sales Growth -25 % 33.33 % 0 % 0 % -46.7 %




Inventory Turnover Ratio Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry # 10
Healthcare Sector # 109
Overall Market # 799

Inventory Turnover Ratio Statistics
High Average Low
4.29 3.1 1.89
(Sep 30 2024)   (Mar 31 2021)




Financial Statements
Elutia Inc 's Inventories $ 4 Millions Visit ELUT's Balance sheet
Elutia Inc 's Cost of Revenues TTM $ 13 Millions Visit ELUT's Income Statement
What are ELUT's Sales? Visit ELUT's Sales by Segment

Other Inventory Turnover Ratios
Elutia Inc 's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Biotechnology & Pharmaceuticals Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
ELUT's Inventory Turnover Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for ELUT's Competitors
Inventory Turnover Ratio for ELUT's Suppliers
Inventory Turnover Ratio for ELUT's Customers

You may also want to know
ELUT's Sales Growth Rates ELUT's Pe Price to earnings ratio ELUT's Receivables Turnover Ratio ELUT's Stock Quote
ELUT's Net Income Growth Rates ELUT's Ps Price to Sales ratio ELUT's Sales per Employee ELUT's Asset Turnover Ratio
ELUT's Net Margin ELUT's Pb Price to Book ratio ELUT's Financial Strength Ratios ELUT's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Mar 31 2025, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Mar 31 2025 Inventories at quarter ending Mar 31 2025
Opko Health Inc   8.19 $ 492.091  Millions$ 60  Millions
Blue Water Vaccines Inc  8.08 $ 1.013  Millions$ 0  Millions
Collegium Pharmaceutical inc   7.99 $ 277.000  Millions$ 35  Millions
National Vision Holdings Inc   7.98 $ 720.580  Millions$ 90  Millions
Lantheus Holdings Inc   7.93 $ 552.000  Millions$ 70  Millions
Twist Bioscience Corporation  7.65 $ 185.307  Millions$ 24  Millions
Inogen Inc   7.44 $ 183.218  Millions$ 25  Millions
Cardiff Lexington Corporation  7.35 $ 3.969  Millions$ 1  Millions
Nutriband Inc   7.33 $ 1.501  Millions$ 0  Millions
Charles River Laboratories International inc   7.20 $ 2,256.492  Millions$ 314  Millions
Hims and Hers Health Inc   7.11 $ 409.000  Millions$ 58  Millions
Warby Parker Inc   6.86 $ 355.000  Millions$ 52  Millions
Fonar Corporation  6.81 $ 18.904  Millions$ 3  Millions
Owens and Minor inc   6.79 $ 8,510.000  Millions$ 1,254  Millions
Vanda Pharmaceuticals Inc   6.77 $ 11.395  Millions$ 2  Millions
Adaptive Biotechnologies Corporation  6.72 $ 71.008  Millions$ 11  Millions
Kewaunee Scientific Corporation  6.68 $ 171.000  Millions$ 26  Millions
Star Equity Holdings Inc   6.67 $ 44.548  Millions$ 7  Millions
Carlisle Companies Incorporated  6.62 $ 3,128.400  Millions$ 473  Millions
Neuronetics Inc   6.59 $ 32.000  Millions$ 5  Millions
Tarsus Pharmaceuticals Inc   6.32 $ 16.383  Millions$ 3  Millions
Avantor Inc   5.81 $ 4,441.500  Millions$ 764  Millions
Bionexus Gene Lab Corp   5.75 $ 7.179  Millions$ 1  Millions
Moderna Inc   5.52 $ 1,458.000  Millions$ 264  Millions
Veracyte Inc   5.42 $ 116.021  Millions$ 21  Millions
Strata Skin Sciences Inc   5.42 $ 14.000  Millions$ 3  Millions
Exact Sciences Corporation  5.39 $ 812.749  Millions$ 151  Millions
23andme Holding Co   5.35 $ 89.000  Millions$ 17  Millions
Flora Growth Corp   5.29 $ 37.472  Millions$ 7  Millions
Harrow Inc   5.29 $ 54.216  Millions$ 10  Millions

Date modified: 2025-05-15T07:40:47+00:00




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com